All Articles
View Report
Diaceutics reviews the ongoing debate on diagnostics reform legislation

Diaceutics reviews the ongoing debate on diagnostics reform legislation

23 May, 2019

Thought leaders at Diaceutics recently authored a peer-reviewed article that covers the ongoing national debate over diagnostics reform legislation in the United States. The article is now available online ahead of print in the Journal of Molecular Diagnostics (May 2019). Citing the roots of this controversy, the authors cover the need for clinical laboratory standardization and harmonization as important keys to any regulatory reform.

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.